99 related articles for article (PubMed ID: 7575733)
1. Cytarabine therapy for refractory cutaneous lupus.
Yung RL; Richardson BC
Arthritis Rheum; 1995 Sep; 38(9):1341-3. PubMed ID: 7575733
[No Abstract] [Full Text] [Related]
2. Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy.
Fernandes NF; Rosenbach M; Elenitsas R; Kist JM
Arch Dermatol; 2009 Mar; 145(3):340-1. PubMed ID: 19289781
[No Abstract] [Full Text] [Related]
3. Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy. The Japan Adult Leukemia Study Group.
Miyawaki S; Kobayashi T; Tanimoto M; Kuriyama K; Murakami H; Yoshida M; Minami S; Minato K; Tsubaki K; Omoto E; Oh H; Jinnai I; Sakamaki H; Hiraoka A; Kanamaru A; Takahashi I; Saito K; Naoe T; Yamada O; Asou N; Kageyama S; Emi N; Ueda T; Tomonaga M; Ohno R
Int J Hematol; 1999 Jul; 70(1):56-7. PubMed ID: 10446497
[No Abstract] [Full Text] [Related]
4. Neutrophilic eccrine hidradenitis induced by cytarabine.
Grahovac M; Maximiliane Ehmann L; Flaig M; Reibke R; Wollenberg A
Acta Dermatovenerol Croat; 2012; 20(4):272-5. PubMed ID: 23317491
[No Abstract] [Full Text] [Related]
5. Cerebellar toxicity due to cytarabine: A series of 4 cases.
Sainz de la Maza Cantero S; Jiménez Martín A; de Felipe Mimbrera A; Corral Corral Í
Neurologia; 2016 Sep; 31(7):491-2. PubMed ID: 25728956
[No Abstract] [Full Text] [Related]
6. Cytarabine-induced neurotoxicity responding to methyl prednisolone.
Malhotra P; Mahi S; Lal V; Kumari S; Jain S; Varma S
Am J Hematol; 2004 Dec; 77(4):416. PubMed ID: 15551283
[No Abstract] [Full Text] [Related]
7. Aseptic meningitis in a child after systemic treatment with high dose cytarabine.
Pease CL; Horton TM; McClain KL; Kaplan SL
Pediatr Infect Dis J; 2001 Jan; 20(1):87-9. PubMed ID: 11176579
[TBL] [Abstract][Full Text] [Related]
8. [Petechiae, suffusions and cytarabine-induced erythema in treatment of acute myeloid leukemia].
Taverna C; Jacky E; Sauter C
Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1117. PubMed ID: 9691347
[No Abstract] [Full Text] [Related]
9. Capecitabine-induced Subacute Cutaneous Lupus Erythematosus.
Rocha A; Almeida HL; Zerwes G; Oliveira Filho UL
An Bras Dermatol; 2019; 94(5):618-619. PubMed ID: 31777367
[No Abstract] [Full Text] [Related]
10. [Ara-C].
Onozawa M; Teshima T
Nihon Rinsho; 2015 Feb; 73 Suppl 2():623-7. PubMed ID: 25831835
[No Abstract] [Full Text] [Related]
11. Resident rounds. Part III: Neutrophilic eccrine hidradenitis in the setting of acute myelogenous leukemia treated with cytarabine.
Shlapak D; Kerisit K; Lin C; Wang A; Stumpf B
J Drugs Dermatol; 2013 Feb; 12(2):231-2. PubMed ID: 23550319
[No Abstract] [Full Text] [Related]
12. Methotrexate treatment for refractory subacute cutaneous lupus erythematosus.
Kuhn A; Specker C; Ruzicka T; Lehmann P
J Am Acad Dermatol; 2002 Apr; 46(4):600-3. PubMed ID: 11907517
[TBL] [Abstract][Full Text] [Related]
13. High-dose cytarabine as salvage therapy for relapsed or refractory acute myeloid leukemia--is more better or more of the same?
Wolach O; Itchaki G; Bar-Natan M; Yeshurun M; Ram R; Herscovici C; Shpilberg O; Douer D; Tallman MS; Raanani P
Hematol Oncol; 2016 Mar; 34(1):28-35. PubMed ID: 25689584
[TBL] [Abstract][Full Text] [Related]
14. Pulse cyclophosphamide treatment for severe refractory cutaneous lupus erythematosus.
Raptopoulou A; Linardakis C; Sidiropoulos P; Kritikos HD; Boumpas DT
Lupus; 2010 May; 19(6):744-7. PubMed ID: 20179172
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine.
Weger W; Kränke B; Gerger A; Salmhofer W; Aberer E
J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S4-6. PubMed ID: 18625380
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of liposomal cytarabine in neoplastic meningitis].
Rudà R; Leoncini B; Laguzzi E; Trevisan E; Guarneri D; Bertetto O; Soffietti R
Tumori; 2007; 93(3):suppl 4-5. PubMed ID: 17679479
[No Abstract] [Full Text] [Related]
17. Isolated hyperbilirubinemia following standard dose cytosine arabinoside in a patient with relapsed acute myeloid leukemia.
Altundag O; Altundag K; Celik I; Turker A; Kars A
Am J Hematol; 2004 Apr; 75(4):263-4. PubMed ID: 15054828
[No Abstract] [Full Text] [Related]
18. Cytosine-arabinoside induced bradycardia in patient with non-Hodgkin lymphoma: a case report.
Cil T; Kaplan MA; Altintas A; Pasa S; Isikdogan A
Leuk Lymphoma; 2007 Jun; 48(6):1247-9. PubMed ID: 17577797
[No Abstract] [Full Text] [Related]
19. Cutaneous lupus erythematosus.
Eastham AB; Vleugels RA
JAMA Dermatol; 2014 Mar; 150(3):344. PubMed ID: 24623331
[No Abstract] [Full Text] [Related]
20. Where Should We Position Antimalarial Drug Combinations in the Management of Refractory Cutaneous Lupus Erythematosus?
Pérez-López I; Martínez-López A; Tercedor-Sánchez J; Ruiz-Villaverde R
Actas Dermosifiliogr; 2016; 107(6):521-2. PubMed ID: 26762693
[No Abstract] [Full Text] [Related]
[Next] [New Search]
